Top Stocks To Buy For Long Term

 

The Ultimate List of Top Stocks To Buy For Long Term Wealth Creation

 Table of Contents

1. Introduction

2. Campbell’s CPB

3. Yum China Holdings YUMC

4. Coloplast CLPBY

5. GSK GSK

6. Constellation Brands STZ

7. FAQ's

1 Introduction

The US market is again starting to look expensive because of rising inflation and rising interest rates. Due to this, investors are thinking about which stocks to buy in this background.

In whatever direction the market goes, investors would like to invest in companies that provide some certainty in terms of cash flow and fundamentals of the company. And that is why we have done this blog well. Which companies have the potential to become multibaggers in the future, so we have studied them in as much detail as possible.

Nobody knows whether a company is undervalued or overvalued; it is an estimate of study and analysis, so here we have focused on the 10 best companies with the lowest valuation shares.

·        10 Best Stocks to Buy Now—August 2025

-        Here are the top 10 most undervalued stocks as per our analysis till August 3, 2025

1.      Campbell’s CPB

2.      Yum China Holdings YUMC

3.      Coloplast CLPBY

4.      GSK GSK

5.      Constellation Brands STZ

Here's why we like these companies at these prices, as well as key metrics from our blog. All data is as of market close on August 3, 2025

2) Campbell’s

·        Price/Fair Value: 0.52

·        Uncertainty Rating:  Medium

·        Capital Allocation Rating: Standard

• Industry: Packaged Foods

Campbell's stock is the lowest price on this month's buy list. The company is successful thanks to its products and brands, including its namesake brand, Pace, Prego, and Swanson. Research shows that Campbell's politics are solid. By leveraging technology, data insights, and artificial intelligence, the company brings products to shelves on time that consumers appreciate. He adds, "We believe Campbell is committed to eliminating inefficiencies from its supply chain and distribution network, optimizing direct-to-store routes, and investing in automation. Campbell recently announced plans to unlock savings of $250 million by fiscal year 2018. Similarly, the company's supply chain network works very well, due to which the company's growth is happening well, and we should take advantage of this.

3) Yum China Holdings

·        Price/Fair Value: 0.61

·        Uncertainty Rating: Medium

·        Capital Allocation Rating: Standard

•      Industry: Restaurants

Campbell's stock is the lowest price on this month's buy list. The company is successful thanks to its products and brands, including its namesake brand, Pace, Prego, and Swanson. Research shows that Campbell's politics are solid. By leveraging technology, data insights, and artificial intelligence, the company brings products to shelves on time that consumers appreciate. He adds, "We believe Campbell is committed to eliminating inefficiencies from its supply chain and distribution network, optimizing direct-to-store routes, and investing in automation. Campbell recently announced plans to unlock savings of $250 million by fiscal year 2018. Similarly, the company's supply chain network works very well, due to which the company's growth is happening well, and we should take advantage of this.

4) Coloplast

·        Price/Fair Value: 0.67

·        Uncertainty Rating: Medium

·        Capital Allocation Rating: Exemplary

• Industry: Medical Instruments and Supplies

Coloplast's name cannot be left off of the purchasing list.  First off, at 33 percent, Coloplast seems cheap.  Coloplast, a Danish company, is a pioneer in ostomy and continence treatment worldwide.  According to analysis, the company has a long history of consistent and significant innovation, which has helped it grow in the US and take the lead in Europe.  in contrast to our estimated fair value of $14.10 per share since 2008.  As it concentrates on profitable growth, the company has done a good job of figuring out its cost structure.  Coloplast is now concentrating on expanding into new regions to boost growth, with a particular emphasis on the US.  Investors are considering making bulk purchases as a result of this growing expansion.

5) GSK

·        Price/Fair Value: 0.67

·        Uncertainty Rating: Medium

·        Capital Allocation Rating: Standard

• Industry: Drug Manufacturers—General

Several senior analysts believe GSK's innovative new product lines and its list of patent-protected claims create a broad economic advantage, as GSK's diverse drug portfolio protects the company from problems associated with any single product, and its many patented drugs has been positioned separately in the market. GSK's strong product pipeline is the result of a shift in order strategy; the company has moved from previously focusing on modest improvements to now focusing on true innovation, expanding into emerging markets. We expect GSK to be a contender in the HIV and vaccines areas in the next year. GSK's stock is trading at 38% below our fair value estimate of 58 per share.

6) Constellation Brands

·        Price/Fair Value: 0.69

·        Uncertainty Rating: Medium

·        Capital Allocation Rating: Standard

•       Industry: Beverages—Brewers

Constellation Brands holds the largest share in the beer, wine, and spirits category in the United States, generating 80% of revenue from Mexican imports under the brands and brands selling beer. While overall beer volumes in the US have remained stable, Constellation has taken advantage of the favorable conditions of the premium current to boost volume growth, marking a high point in previous years. Veteran analysts acknowledge near-term demand challenges due to their gearing, but the Concepcion brand will continue to benefit from consumer loyalty and a solid news/helpline project. Constellation Brands' shares are trading at a 21% discount to our fair value estimate, and hence we see valuations in these markets, due to which their demand may increase in the future.

7) FAQ’S

1) Which is the best stock to invest for long term?

There’s no single “best” stock, but fundamentally strong companies like Apple, Microsoft, Amazon, and Berkshire Hathaway are often considered good long-term picks due to their consistent growth, strong balance sheets, and market leadership.

2) Which stock gives 100% return?

While no stock can guarantee a 100% return, high-growth sectors like technology (e.g., Nvidia, Tesla) or renewable energy (e.g., Enphase Energy, First Solar) have historically shown strong potential. However, such returns usually come with higher risk and time horizon.

3) Which stocks will boom in 2025?

Stocks in sectors like AI, semiconductors, green energy, and defense are projected to see strong growth by 2025. Companies like Nvidia, AMD, Palantir, and Lockheed Martin are often highlighted by analysts for potential outperformance.